Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
Mahamaya Lifesciences Ltd. IPO is a Book Build Issue
The equity shares are proposed to be listed on the BSE SME. Oneview Corporate Advisors Pvt.Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue. Key details like IPO dates, IPO price bands and lot size are yet to be announced.
Refer to Mahamaya Lifesciences IPO DRHP for more details.
| IPO Date | [.] |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Issue Price Band | [.] to [.] per share |
| Lot Size | |
| Sale Type | Fresh Capital-cum-Offer for Sale |
| Fresh Issue | 56,38,800 shares (aggregating up to ₹[.] Cr) |
| Offer for Sale | 5,40,000 shares of ₹10 (aggregating up to ₹[.] Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Share Holding Pre Issue | 1,77,66,200 shares |
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Net Offer |
| Retail Shares Offered | Not less than 35.00% of the Net Offer |
| NII Shares Offered | Not more than 15% of the Net Offer |
| Description | Date |
|---|---|
| Filed with SEBI/Exchange | Thu, Feb 27, 2025 |
| SEBI/Exchange approval received | Thu, Aug 7, 2025 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in 2002, Mahamaya Lifesciences Limited is engaged in manufacturing, registration and export of finest crop protection products and bioproducts for crop & soil health management and to help the farming community for more productivity.
The company specializes in manufacturing pesticide formulations and supplying bulk products to Indian agrochemical companies and multinational corporations (MNCs).
The company imports carefully researched molecules, registers them with the Central Insecticides Board, and markets them as technical and value-added formulations for domestic manufacturers and multinational corporations (MNCs).
The company has invested in global product registrations, with active markets in countries like the Dominican Republic, Egypt, Ethiopia, Jordan, UAE, and Turkey, offering high-quality products and data support for registrations.
Product Portfolio:
As of February 27, 2025, the company had 65 employees.
Competitive Strengths:
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 151.95 | 112.07 | 77.88 | 55.71 |
| Total Income | 147.15 | 162.83 | 137.4 | 90.16 |
| Profit After Tax | 7.41 | 5.22 | 3.75 | 2.72 |
| Net Worth | 45.86 | 24.66 | 19.44 | 15.71 |
| Reserves and Surplus | 28.1 | 23.41 | 18.19 | 14.46 |
| Total Borrowing | 48.3 | 54.63 | 24.37 | 19.17 |
| Amount in ₹ Crore | ||||
| KPI | Values |
|---|---|
| ROE | 23.67% |
| ROCE | 32.38% |
| RoNW | 21.16% |
| PAT Margin | 3.20% |
The Company intends to utilize the net proceeds in following objects:
The Company will not receive any proceeds from the Offer for Sale and the proceeds received from the Offer for Sale will not form part of the Net Proceeds.
Mahamaya Lifesciences Ltd.
Unit No: DPT – 033, Ground Floor,
Plot No: 79 – 80, DLF Prime Tower,
Block, Okhla, Phase – 1
Delhi, New Delhi, 110020
Phone: +91-1146561474
Email: cs@mahamayalifesciences.com
Website: https://www.mahamayalifesciences.com/
Kfin Technologies Ltd.
Phone: 04067162222, 04079611000
Email: mahamaya.ipo@kfintech.com
Website: https://ipostatus.kfintech.com/
Mahamaya Lifesciences IPO is a SME IPO of 0 equity shares of the face value of ₹10 aggregating up to ₹[.] Crores. The issue is priced at . The minimum order quantity is .
The Mahamaya Lifesciences IPO open and close dates are not available as of now.
Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
Zerodha customers can apply online in Mahamaya Lifesciences IPO using UPI as a payment gateway. Zerodha customers can apply in Mahamaya Lifesciences IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Mahamaya Lifesciences IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Mahamaya Lifesciences IPO dates are not announced. Please check back again after some time.
Mahamaya Lifesciences IPO lot size and the minimum order quantity is not available at this time. Please check again later.
You can apply in Mahamaya Lifesciences IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Mahamaya Lifesciences IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Mahamaya Lifesciences IPO allotment status.
The Mahamaya Lifesciences IPO listing date is not yet announced. The tentative date of Mahamaya Lifesciences IPO listing is [.].
Useful Articles
